Get started
Author

Hend Mohamed El Tayebi

Observed names: El Tayebi HM, H. El-Tayebi, H. M. El Tayebi, H.M. El Tayebi, HEND M. EL TAYEBI, HEND MOHAMED EL TAYEBI, Hend El Tayebi, Hend Eltayebi, Hend M El Tayebi, Hend M. El Tayebi, Hend M. El-Tayebi, Hend M. ElTayebi, Hend M. El Tayebi, Hend M. El‑Tayebi, Hend Mohamed El-Tayebi, Hend Tayebi, Hend.M. El Tayebi
ORCID: 0000-0002-6896-6018
Observed ORCIDs: 0000-0002-6896-6018, 0009-0005-2392-7436
OpenAlex ID: A5081593160
MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-Myc
2016 · Rana Ahmed Youness, Hend Mohamed El-Tayebi, et al. · Oncology Letters · 85
PDF
miR‐1275: A single microRNA that targets the three IGF2‐mRNA‐binding proteins hindering tumor growth in hepatocellular carcinoma
2015 · Injie Omar Fawzy, Mohammed Tarif Hamza, et al. · FEBS Letters · 68
Destabilizing the interplay between miR-1275 and IGF2BPs by Tamarix articulata and quercetin in hepatocellular carcinoma
2017 · Yasmin M. Shaalan, H. Handoussa, et al. · Natural Product Research · 66
XIST and TSIX: Novel Cancer Immune Biomarkers in PD-L1-Overexpressing Breast Cancer Patients
2020 · Esraa A. Salama, Reda E. Adbeltawab, et al. · Frontiers in Oncology · 60
PDF
Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor progression
2016 · Rana Ahmed Youness, Mai Atef Rahmoon, et al. · Growth Factors · 58
miR‐615‐5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma
2012 · H.M. El Tayebi, K.A. Hosny, et al. · FEBS Letters · 55
MiR-615-5p depresses natural killer cells cytotoxicity through repressing IGF-1R in hepatocellular carcinoma patients
2017 · Mai Atef Rahmoon, Rana Ahmed Youness, et al. · Growth Factors · 52
The Monocyte, a Maestro in the Tumor Microenvironment (TME) of Breast Cancer
2022 · Hoda T. Amer, Ulrike Stein, et al. · Cancers · 42
PDF
Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis
2018 · Aya El Khodiry, Menna Afify, et al. · World Journal of Gastroenterology · 34
PDF
Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges
2022 · Monica A. Kamal, Yasmine M. Mandour, et al. · Molecules · 33
PDF
GPI-AP: Unraveling a New Class of Malignancy Mediators and Potential Immunotherapy Targets
2020 · Nada H. Hussein, Nada S. Amin, et al. · Frontiers in Oncology · 31
PDF
CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negative Breast Cancer
2022 · Alaa M. Ghallab, Reda A. Eissa, et al. · Frontiers in Pharmacology · 30
Oleuropin controls miR-194/XIST/PD-L1 loop in triple negative breast cancer: New role of nutri-epigenetics in immune-oncology
2021 · Marwa M. Hamed, Heba Handoussa, et al. · Life Sciences · 28
Transcriptional activation of the IGF-II/IGF-1R axis and inhibition of IGFBP-3 by miR-155 in hepatocellular carcinoma
2015 · HEND M. EL TAYEBI, AMR A. WALY, et al. · Oncology Letters · 28
PDF
Repression of miR-17-5p with elevated expression of E2F-1 and c-MYC in non-metastatic hepatocellular carcinoma and enhancement of cell growth upon reversing this expression pattern
2013 · H.M. El Tayebi, K. Omar, et al. · Biochemical and Biophysical Research Communications · 26
Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients?
2021 · Sawsan Elgohary, Aya A. Elkhodiry, et al. · Cells · 25
PDF
Long non‑coding RNAs XIST and MALAT1 hijack the PD‑L1 regulatory signaling pathway in breast cancer subtypes
2021 · Amany Samir, Reda Tawab, et al. · Oncology Letters · 24
PDF
Methylation in MIRLET7A3 Gene Induces the Expression of IGF-II and Its mRNA Binding Proteins IGF2BP-2 and 3 in Hepatocellular Carcinoma
2019 · Amr A. Waly, Nada El-Ekiaby, et al. · Frontiers in Physiology · 23
PDF
A pleiotropic effect of the single clustered hepatic metastamiRs miR-96-5p and miR-182-5p on insulin-like growth factor II, insulin-like growth factor-1 receptor and insulin-like growth factor-binding protein-3 in hepatocellular carcinoma
2012 · REEM AMR ASSAL, HEND MOHAMED EL TAYEBI, et al. · Molecular Medicine Reports · 23
PDF
Expression of insulin-like growth factor-II, matrix metalloproteinases, and their tissue inhibitors as predictive markers in the peripheral blood of HCC patients
2011 · H.M. El Tayebi, W. Salah, et al. · Biomarkers · 23
PDF
A cutting-edge immunomodulatory interlinkage between HOTAIR and MALAT1 in tumor-associated macrophages in breast cancer: A personalized immunotherapeutic approach
2022 · Hoda T. Amer, Reda A. Eissa, et al. · Frontiers in Molecular Biosciences · 21
PDF
Scavenging the hidden impacts of non-coding RNAs in multiple sclerosis
2021 · Aya A. Elkhodiry, Hend M. El Tayebi · Non-coding RNA Research · 17
PDF
Pivotal role of long non-coding ribonucleic acid-X-inactive specific transcript in regulating immune checkpoint programmed death ligand 1 through a shared pathway between miR-194-5p and miR-155-5p in hepatocellular carcinoma
2020 · Sara M Atwa, Heba Handoussa, et al. · World Journal of Hepatology · 17
MALAT-1: LncRNA ruling miR-182/PIG-C/mesothelin triad in triple negative breast cancer
2020 · Farida S. Barsoum, Amany S. Awad, et al. · Pathology - Research and Practice · 16
The impact of metformin use on the outcomes of relapse-remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open-label randomized controlled trial
2023 · Mohamed Y. Abdelgaied, Mohamed Hamed Rashad, et al. · Journal of Neurology · 15
Works count: 83
Citation count: 1,067
H-index: 21
I10-index: 31
Year
Topic
Type